Smith & Nephew plc (SNNUF)
OTCMKTS
· Delayed Price · Currency is USD
12.56
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Smith & Nephew Revenue
In the year 2024, Smith & Nephew had annual revenue of $5.81B with 4.70% growth. Smith & Nephew had revenue of $2.98B in the half year ending December 31, 2024, with 14.07% growth.
Revenue
5.81B
Revenue Growth
+4.70%
P/S Ratio
2.01
Revenue / Employee
334.89K
Employees
17,349
Market Cap
11.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 20.65M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Smith & Nephew News
- 4 days ago - Smith & Nephew: Underappreciated Recovery With Strategic Upside - Seeking Alpha
- 21 days ago - Trump tariffs: these two European healthcare stocks face the highest US revenue exposure - Invezz
- 6 weeks ago - Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025 - GlobeNewsWire
- 6 weeks ago - Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025 - GlobeNewsWire
- 7 weeks ago - Smith & Nephew PLC (SNN) Achieves Milestone in Hip Replacement Technology - GuruFocus
- 7 weeks ago - New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty - GlobeNewsWire
- 7 weeks ago - Smith & Nephew gains after report it may evaluate a break-up - Seeking Alpha
- 7 weeks ago - Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research - GlobeNewsWire